Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer Inc discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally.

Large Cap US Pick List – November 2024

Privacy Policy | No cost, no obligation to buy anything ever.Past performance is no guarantee of future results. The facts discussed here and much other information on Zacks.com might help determine whether or not it’s worthwhile paying attention to the market buzz about Pfizer. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.

Earnings Estimate Revisions

© 2024 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.

Zacks Mobile App

• Discover which analysts rank highest on predicting the price target of PFE.
• Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.
• Barclays raised their target price on Pfizer from $30.00 to $32.00 and gave the stock an « equal weight » rating in a research note on Wednesday, July 31st.
• Top institutional investors of Pfizer include State Street Corp (5.13%), Wellington Management Group LLP (2.89%), Charles Schwab Investment Management Inc. (2.30%) and Geode Capital Management LLC (2.08%).

The firm has a market cap of $146.38 billion, a PE ratio of 34.91, a P/E/G ratio of 0.83 and a beta of 0.67. Pfizer Inc. has a 52 week low of $24.48 and a 52 week high of $31.54. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer.

Inc. (MRK), Switzerland-based Roche Holding AG (RHHBY), and Eli Lilly and Co. (LLY). Pfizer reported adjusted net income attributable to its common shareholders of $25.2 billion on $81.3 billion in annual revenue in its 2021 fiscal year (FY). Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, tifia forex broker review treatments and cures that challenge the most feared diseases.

As of Aug. 9, 2021, Pfizer had 5,606,688,356 shares of voting common stock outstanding. Yes, Pfizer pays a regular quarterly cash dividend of $0.39 per share. The FDA gave the vaccine full approval on Aug. 23, 2021, after reviewing the biologics license application (BLA) submitted by Pfizer and BioNTech. It was the first COVID-19 vaccine to receive full approval from the FDA. Pfizer Inc.  PFE shares are lower on Thursday due to news that President-elect Donald Trump picked Robert F. Kennedy Jr. as his next secretary of the Department of Health and Human Services.

Top institutional investors of Pfizer include State Street Corp (5.13%), Wellington Management Group LLP (2.89%), Charles Schwab Investment Management Inc. (2.30%) and Geode Capital Management LLC (2.08%). Insiders that own company stock include Pfizer Inc, William R Carapezzi Jr, Jennifer B Damico, Scott Gottlieb and Alexander R Mackenzie. Discover which analysts rank highest on predicting the price target of PFE. Select to analyze similar companies using key performance metrics; select up to 4 stocks. Please bear with us as we address this and restore your personalized lists. EverFX Pfizer (PFE Quick QuotePFE – Free Report) has been one of the most searched-for stocks on Zacks.com lately.

Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap. MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… This instant news alert was generated forex broker by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting.

Projected Revenue Growth

So, you might want to look at some of the facts that could shape the stock’s performance in the near term. Stocks linked to vaccine developers such as Moderna, Pfizer and Novavax tanked in the leadup to market close Thursday, tumbling after reports surfaced that President-elect Donald Trump would select va… Click the link below and we’ll send you MarketBeat’s list of ten stocks that will drive in any economic environment. Our experts picked 7 Zacks Rank #1 Strong Buy stocks with the best chance to skyrocket within the next days. Compared to the Zacks Consensus Estimate of $15.19 billion, the reported revenues represent a surprise of +16.53%.